 |
 |

Guidelines for Handling Parenteral Antineoplastics
Council on Scientific Affairs
JAMA. 1985;253(11):1590-1592.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
BACKGROUND
The growing professional concern over the potential carcinogenic hazards associated with the handling of antineoplastic agents has resulted in the publication of studies concerned with the detection of metagenic effects in hospital staff involved with cancer chemotherapy, as well as publication of numerous guidelines to minimize exposure to antineoplastic agents. Although the actual hazards associated with the handling of parenteral antineoplastic drugs have not been established, the issue of ensuring the safety of all health care personnel is becoming a broader public concern.1
The objectives of this report are to (1) review the scientific data regarding the risks to physicians and other health care personnel in handling and administering parenteral antineoplastic drugs; (2) study the guidelines recommended by the National Institutes of Health (NIH) and other sources for the safe handling of parenteral antineoplastic drugs; and (3) determine whether the currently available guidelines are adequate to ensure safe
. . . [Full Text PDF of this Article]
Author Affiliations
From the Council on Scientific Affairs, Division of Drugs and Technology, American Medical Association, Chicago.
Footnotes
Report D of the Council on Scientific Affairs, adopted by the House of Delegates of the American Medical Association at the Interim Meeting, December 1984.
This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and patterns of practice evolve. This report reflects the views of scientific experts and reports in the scientific literature as of December 1984.
Reprint requests to Council on Scientific Affairs, Division of Drugs and Technology, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (John C. Ballin, PhD).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|